Abbott India

{
  "main_header": {
    "sid": 919728,
    "name": "Abbott India",
    "stock_name": "Abbott India",
    "full_name": "Abbott India Ltd.",
    "name_url": "stocks-analysis/abbott-india",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "26,661.45",
    "chg": -30.7,
    "chgp": "-0.12%",
    "dir": -1,
    "prev_price": "26,692.15",
    "mcapval": "56,574.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500488,
    "symbol": "ABBOTINDIA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE358A01014",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "12.46 k",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/abbott-india-919728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Abbott India Gains 4.86%: 3 Key Factors Driving This Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-gains-486-3-key-factors-driving-this-weeks-momentum-3983282",
        "imagepath": "",
        "date": "2026-05-09 14:06:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at ₹25,426.70</p>\n                    <p><strong>6 May:</strong> Sharp 3.84% price jump to ₹26,295.50</p>\n                    <p><strong>7 May:</strong> Mojo Grade upgraded to Hold amid mixed technical and valuation signals</p>\n                    <p><strong>8 May:</strong> Week closes at ₹26,661.45, up 4.86% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.25,426.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.26,661.45</div><div class=\"st..."
      },
      {
        "title": "Abbott India Ltd. Upgraded to Hold by MarketsMOJO Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/abbott-india-ltd-upgraded-to-hold-by-marketsmojo-amid-mixed-technical-and-valuation-signals-3979072",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AbbottIndiaLtd_mojoScore_3979072.png",
        "date": "2026-05-07 08:21:43",
        "description": "Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 6 May 2026. This shift reflects nuanced changes across four critical parameters: quality, valuation, financial trend, and technicals. Despite a challenging recent performance, the company’s strong fundamentals and evolving market signals have prompted a reassessment of its outlook."
      },
      {
        "title": "Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3978912",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AbbottIndiaLtd_technicaldot_3978912.png",
        "date": "2026-05-07 08:05:24",
        "description": "Abbott India Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. This change accompanies a 3.84% gain in the stock price on 7 May 2026, reflecting renewed investor interest despite mixed signals from key technical indicators."
      },
      {
        "title": "Abbott India Ltd: Valuation Shift Signals Price Attractiveness Change Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-valuation-shift-signals-price-attractiveness-change-amid-sector-dynamics-3978735",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AbbottIndiaLtd_valuationdot_3978735.png",
        "date": "2026-05-07 08:01:45",
        "description": "Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an expensive to a very expensive rating. This change reflects evolving market perceptions and raises questions about the stock’s price attractiveness relative to its historical averages and peer group benchmarks."
      },
      {
        "title": "Abbott India Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/abbott-india-ltd-is-rated-sell-by-marketsmojo-3973080",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AbbottIndiaLtd_mojoScore_3973080.png",
        "date": "2026-05-04 10:10:44",
        "description": "Abbott India Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Markets Rally, But Abbott India Ltd. Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-stock-falls-to-52-week-low-of-rs25164-3963944",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AbbottIndiaLtd_priceRelatedfactors_3963944.png",
        "date": "2026-04-27 09:42:24",
        "description": "Despite a broadly positive market backdrop, Abbott India Ltd. has slid to a fresh 52-week low of Rs 25,164 on 27 Apr 2026, marking a 15.16% decline over the past year and underperforming the Sensex by a wide margin. This divergence raises questions about the underlying factors weighing on the stock amid a rally in mega caps and a Sensex trading 0.43% higher."
      },
      {
        "title": "Abbott India Ltd Falls 2.32%: 3 Key Factors Behind the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-falls-232-3-key-factors-behind-the-weekly-decline-3962506",
        "imagepath": "",
        "date": "2026-04-25 14:04:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Apr 20:</strong> Stock opens at Rs.25,578.90, down 0.85%</p>\n                    <p><strong>Apr 21:</strong> Valuation downgrade announced; Mojo Grade cut to Sell</p>\n                    <p><strong>Apr 22:</strong> Stock hits 52-week low of Rs.25,315.55 amid market weakness</p>\n                    <p><strong>Apr 23:</strong> Slight recovery with modest gains on heavy volume</p>\n                    <p><strong>Apr 24:</strong> Stock falls again to 52-week low of Rs.25,310.5, closing the week lower</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.25,797.15</..."
      },
      {
        "title": "Markets Rally, But Abbott India Ltd. Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/abbott-india-ltd-stock-falls-to-52-week-low-of-rs253105-3960380",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AbbottIndiaLtd_priceRelatedfactors_3960380.png",
        "date": "2026-04-24 09:44:08",
        "description": ""
      },
      {
        "title": "Abbott India Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/abbott-india-ltd-is-rated-sell-by-marketsmojo-3958875",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AbbottIndiaLtd_mojoScore_3958875.png",
        "date": "2026-04-23 10:11:04",
        "description": "Abbott India Ltd. is rated Sell by MarketsMOJO, with this rating last updated on 09 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 235,
    "sid": "919728",
    "stock_news_url": "https://www.marketsmojo.com/news/abbott-india-919728"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Considering Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 Along With The Audit Report Of The Statutory Auditors Thereon And To Recommend Final Dividend For The Financial Year E",
      "datetime": "30-Apr-2026",
      "details": "Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 inter alia to consider and approve Audited Financial Results of the Company for the quarter and financial year ended March 31 2026 along with the Audit Report of the Statutory Auditors thereon and to recommend final dividend for the financial year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Abbott India Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24239MH1944PLC007330</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Sangeeta Shetty <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: investorrelations.india@abbott.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Maithilee Mistry <br/> Designation: Chief Financial Officer <br/> EmailId: investorrelations.india@abbott.com</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "22-Apr-2026",
      "details": "Outcome of Board Meeting.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "11 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Abbott India Ltd. has declared <strong>4750%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Abbott India Gains 4.86%: 3 Key Factors Driving This Week’s Momentum

2026-05-09 14:06:56

Key Events This Week

4 May: Week opens at ₹25,426.70

6 May: Sharp 3.84% price jump to ₹26,295.50

7 May: Mojo Grade upgraded to Hold amid mixed technical and valuation signals

8 May: Week closes at ₹26,661.45, up 4.86% for the week

Week Open

Rs.25,426.70

Week Close

Rs.26,661.45

Read full news article

Abbott India Ltd. Upgraded to Hold by MarketsMOJO Amid Mixed Technical and Valuation Signals

2026-05-07 08:21:43

Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 6 May 2026. This shift reflects nuanced changes across four critical parameters: quality, valuation, financial trend, and technicals. Despite a challenging recent performance, the company’s strong fundamentals and evolving market signals have prompted a reassessment of its outlook.

Read full news article

Abbott India Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-07 08:05:24

Abbott India Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. This change accompanies a 3.84% gain in the stock price on 7 May 2026, reflecting renewed investor interest despite mixed signals from key technical indicators.

Read full news article

Abbott India Ltd: Valuation Shift Signals Price Attractiveness Change Amid Sector Dynamics

2026-05-07 08:01:45

Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an expensive to a very expensive rating. This change reflects evolving market perceptions and raises questions about the stock’s price attractiveness relative to its historical averages and peer group benchmarks.

Read full news article

Abbott India Ltd. is Rated Sell by MarketsMOJO

2026-05-04 10:10:44

Abbott India Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Markets Rally, But Abbott India Ltd. Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-04-27 09:42:24

Despite a broadly positive market backdrop, Abbott India Ltd. has slid to a fresh 52-week low of Rs 25,164 on 27 Apr 2026, marking a 15.16% decline over the past year and underperforming the Sensex by a wide margin. This divergence raises questions about the underlying factors weighing on the stock amid a rally in mega caps and a Sensex trading 0.43% higher.

Read full news article

Abbott India Ltd Falls 2.32%: 3 Key Factors Behind the Weekly Decline

2026-04-25 14:04:19

Key Events This Week

Apr 20: Stock opens at Rs.25,578.90, down 0.85%

Apr 21: Valuation downgrade announced; Mojo Grade cut to Sell

Apr 22: Stock hits 52-week low of Rs.25,315.55 amid market weakness

Apr 23: Slight recovery with modest gains on heavy volume

Apr 24: Stock falls again to 52-week low of Rs.25,310.5, closing the week lower

Week Open

Rs.25,797.15Read full news article

Markets Rally, But Abbott India Ltd. Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-04-24 09:44:08

Read full news article

Abbott India Ltd. is Rated Sell by MarketsMOJO

2026-04-23 10:11:04

Abbott India Ltd. is rated Sell by MarketsMOJO, with this rating last updated on 09 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

View All News